Critical Care (Dec 2020)
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
- Jesús F. Bermejo-Martin,
- Milagros González-Rivera,
- Raquel Almansa,
- Dariela Micheloud,
- Ana P. Tedim,
- Marta Domínguez-Gil,
- Salvador Resino,
- Marta Martín-Fernández,
- Pablo Ryan Murua,
- Felipe Pérez-García,
- Luis Tamayo,
- Raúl Lopez-Izquierdo,
- Elena Bustamante,
- César Aldecoa,
- José Manuel Gómez,
- Jesús Rico-Feijoo,
- Antonio Orduña,
- Raúl Méndez,
- Isabel Fernández Natal,
- Gregoria Megías,
- Montserrat González-Estecha,
- Demetrio Carriedo,
- Cristina Doncel,
- Noelia Jorge,
- Alicia Ortega,
- Amanda de la Fuente,
- Félix del Campo,
- José Antonio Fernández-Ratero,
- Wysali Trapiello,
- Paula González-Jiménez,
- Guadalupe Ruiz,
- Alyson A. Kelvin,
- Ali Toloue Ostadgavahi,
- Ruth Oneizat,
- Luz María Ruiz,
- Iria Miguéns,
- Esther Gargallo,
- Ioana Muñoz,
- Sara Pelegrin,
- Silvia Martín,
- Pablo García Olivares,
- Jamil Antonio Cedeño,
- Tomás Ruiz Albi,
- Carolina Puertas,
- Jose Ángel Berezo,
- Gloria Renedo,
- Rubén Herrán,
- Juan Bustamante-Munguira,
- Pedro Enríquez,
- Ramón Cicuendez,
- Jesús Blanco,
- Jesica Abadia,
- Julia Gómez Barquero,
- Nuria Mamolar,
- Natalia Blanca-López,
- Luis Jorge Valdivia,
- Belén Fernández Caso,
- María Ángeles Mantecón,
- Anna Motos,
- Laia Fernandez-Barat,
- Ricard Ferrer,
- Ferrán Barbé,
- Antoni Torres,
- Rosario Menéndez,
- José María Eiros,
- David J. Kelvin
Affiliations
- Jesús F. Bermejo-Martin
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Milagros González-Rivera
- Department of Laboratory Medicine, Hospital General Universitario Gregorio Marañón
- Raquel Almansa
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Dariela Micheloud
- Emergency Department, Hospital General Universitario Gregorio Marañón
- Ana P. Tedim
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Marta Domínguez-Gil
- Microbiology Service, Hospital Universitario Rio Hortega
- Salvador Resino
- Viral Infection and Immunity Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III
- Marta Martín-Fernández
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Pablo Ryan Murua
- Hospital Universitario Infanta Leonor
- Felipe Pérez-García
- Servicio de Microbiología Clínica, Hospital Universitario Príncipe de Asturias
- Luis Tamayo
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Raúl Lopez-Izquierdo
- Emergency Department, Hospital Universitario Rio Hortega
- Elena Bustamante
- Intensive Care Unit, Hospital Clínico Universitario de Valladolid
- César Aldecoa
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- José Manuel Gómez
- Intensive Care Unit, Hospital General Universitario Gregorio Marañón
- Jesús Rico-Feijoo
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Antonio Orduña
- Microbiology Service, Hospital Clinico Universitario de Valladolid
- Raúl Méndez
- Pulmonology Service, Hospital Universitario y Politécnico de La Fe
- Isabel Fernández Natal
- Clinical Microbiology Department, Complejo Asistencial Universitario de León
- Gregoria Megías
- Microbiology Service, Hospital Universitario de Burgos
- Montserrat González-Estecha
- Department of Laboratory Medicine, Hospital General Universitario Gregorio Marañón
- Demetrio Carriedo
- Intensive Care Unit, Complejo Asistencial Universitario de León
- Cristina Doncel
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Noelia Jorge
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Alicia Ortega
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Amanda de la Fuente
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Félix del Campo
- Pneumology Service, Hospital Universitario Río Hortega/Biomedical Engineering Group, Universidad de Valladolid
- José Antonio Fernández-Ratero
- Intensive Care Unit, Hospital Universitario de Burgos
- Wysali Trapiello
- Clinical Analysis Service. Hospital, Clínico Universitario de Valladolid
- Paula González-Jiménez
- Pulmonology Service, Hospital Universitario y Politécnico de La Fe
- Guadalupe Ruiz
- Clinical Analysis Service. Hospital, Clínico Universitario de Valladolid
- Alyson A. Kelvin
- Department of Microbiology and Immunology, Faculty of Medicine, Canadian Center for Vaccinology CCfV, Dalhousie University
- Ali Toloue Ostadgavahi
- Department of Microbiology and Immunology, Faculty of Medicine, Canadian Center for Vaccinology CCfV, Dalhousie University
- Ruth Oneizat
- Microbiology Service, Hospital Universitario Rio Hortega
- Luz María Ruiz
- Microbiology Service, Hospital Universitario Rio Hortega
- Iria Miguéns
- Emergency Department, Hospital General Universitario Gregorio Marañón
- Esther Gargallo
- Emergency Department, Hospital General Universitario Gregorio Marañón
- Ioana Muñoz
- Emergency Department, Hospital General Universitario Gregorio Marañón
- Sara Pelegrin
- Anesthesiology and Reanimation Service, Hospital Universitario Rio Hortega
- Silvia Martín
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Pablo García Olivares
- Intensive Care Unit, Hospital General Universitario Gregorio Marañón
- Jamil Antonio Cedeño
- Intensive Care Unit, Hospital General Universitario Gregorio Marañón
- Tomás Ruiz Albi
- Pneumology Service, Hospital Universitario Río Hortega/Biomedical Engineering Group, Universidad de Valladolid
- Carolina Puertas
- Department of Laboratory Medicine, Hospital General Universitario Gregorio Marañón
- Jose Ángel Berezo
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Gloria Renedo
- Intensive Care Unit, Hospital Clínico Universitario de Valladolid
- Rubén Herrán
- Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca, (IBSAL)
- Juan Bustamante-Munguira
- Department of Cardiovascular Surgery, Hospital Clínico Universitario de Valladolid
- Pedro Enríquez
- Intensive Care Unit, Hospital Universitario Rio Hortega
- Ramón Cicuendez
- Intensive Care Unit, Hospital Clínico Universitario de Valladolid
- Jesús Blanco
- Intensive Care Unit, Hospital Universitario Rio Hortega
- Jesica Abadia
- Infectious Diseases Clinic, Internal Medicine Department, Hospital Universitario Río Hortega
- Julia Gómez Barquero
- Infectious Diseases Clinic, Internal Medicine Department, Hospital Universitario Río Hortega
- Nuria Mamolar
- Intensive Care Unit, Hospital Clínico Universitario de Valladolid
- Natalia Blanca-López
- Hospital Universitario Infanta Leonor
- Luis Jorge Valdivia
- Intensive Care Unit, Complejo Asistencial Universitario de León
- Belén Fernández Caso
- Clinical Microbiology Department, Complejo Asistencial Universitario de León
- María Ángeles Mantecón
- Microbiology Service, Hospital Universitario de Burgos
- Anna Motos
- Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III
- Laia Fernandez-Barat
- Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III
- Ricard Ferrer
- Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III
- Ferrán Barbé
- Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III
- Antoni Torres
- Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III
- Rosario Menéndez
- Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III
- José María Eiros
- Microbiology Service, Hospital Universitario Rio Hortega
- David J. Kelvin
- Department of Microbiology and Immunology, Faculty of Medicine, Canadian Center for Vaccinology CCfV, Dalhousie University
- DOI
- https://doi.org/10.1186/s13054-020-03398-0
- Journal volume & issue
-
Vol. 24,
no. 1
pp. 1 – 13
Abstract
Abstract Background COVID-19 can course with respiratory and extrapulmonary disease. SARS-CoV-2 RNA is detected in respiratory samples but also in blood, stool and urine. Severe COVID-19 is characterized by a dysregulated host response to this virus. We studied whether viral RNAemia or viral RNA load in plasma is associated with severe COVID-19 and also to this dysregulated response. Methods A total of 250 patients with COVID-19 were recruited (50 outpatients, 100 hospitalized ward patients and 100 critically ill). Viral RNA detection and quantification in plasma was performed using droplet digital PCR, targeting the N1 and N2 regions of the SARS-CoV-2 nucleoprotein gene. The association between SARS-CoV-2 RNAemia and viral RNA load in plasma with severity was evaluated by multivariate logistic regression. Correlations between viral RNA load and biomarkers evidencing dysregulation of host response were evaluated by calculating the Spearman correlation coefficients. Results The frequency of viral RNAemia was higher in the critically ill patients (78%) compared to ward patients (27%) and outpatients (2%) (p < 0.001). Critical patients had higher viral RNA loads in plasma than non-critically ill patients, with non-survivors showing the highest values. When outpatients and ward patients were compared, viral RNAemia did not show significant associations in the multivariate analysis. In contrast, when ward patients were compared with ICU patients, both viral RNAemia and viral RNA load in plasma were associated with critical illness (OR [CI 95%], p): RNAemia (3.92 [1.183–12.968], 0.025), viral RNA load (N1) (1.962 [1.244–3.096], 0.004); viral RNA load (N2) (2.229 [1.382–3.595], 0.001). Viral RNA load in plasma correlated with higher levels of chemokines (CXCL10, CCL2), biomarkers indicative of a systemic inflammatory response (IL-6, CRP, ferritin), activation of NK cells (IL-15), endothelial dysfunction (VCAM-1, angiopoietin-2, ICAM-1), coagulation activation (D-Dimer and INR), tissue damage (LDH, GPT), neutrophil response (neutrophils counts, myeloperoxidase, GM-CSF) and immunodepression (PD-L1, IL-10, lymphopenia and monocytopenia). Conclusions SARS-CoV-2 RNAemia and viral RNA load in plasma are associated with critical illness in COVID-19. Viral RNA load in plasma correlates with key signatures of dysregulated host responses, suggesting a major role of uncontrolled viral replication in the pathogenesis of this disease.
Keywords